Vancomycin Trough, the One Antibiotic Level With a Real Number

Vancomycin has a trough target you can actually quote: 10 to 20 mcg/mL, depending on the indication. In our clinical reference material it is the one antibiotic level published with a verified number and its unit attached.

That makes it worth learning properly. It also makes it a useful lesson in what happens when you try to generalise a number that was never meant to travel.

The target, and the qualifier that comes with it

The published trough is 10 to 20 mcg/mL, and the source states plainly that it is indication dependent. That qualifier is part of the fact, not a footnote to it.

A trough is the level immediately before the next dose, which is the lowest point in the dosing interval. Timing is therefore part of the result. A level drawn at the wrong moment is not a low trough, it is a meaningless number.

So there are two things to get right. The value, and when it was drawn.

Why one target does not fit every infection

The reason the range is broad and indication dependent is that the point of the level is exposure over time, and the exposure a serious deep infection needs is not the exposure a milder one needs.

Practically, that means the target inside that band is set by the indication and by your institution's protocol, not by a flashcard. A trough that is appropriate for one patient can be under target for another with the same drug.

Which is why a question about vancomycin monitoring is usually asking whether you understand the reasoning rather than whether you memorised a boundary.

Vancomycin works by binding a target in bacterial cell wall synthesis and blocking it, and the level is a proxy for how much of that is happening where it matters.

Why this number does not travel to other classes

Here is the part worth carrying. Vancomycin has a published target because the literature supports one. Aminoglycosides largely do not.

The class level source for aminoglycosides states that therapeutic drug monitoring is necessary and that there is no universal agreement on the method. Specific peak and trough targets are drug specific and institution specific.

So the temptation to write a tidy row of antibiotic levels in your notes should be resisted. One row would be sourced. The others would be borrowed.

That comparison, and the way monitoring differs between the two classes, is drawn out in two monitoring stories, vancomycin and aminoglycosides. The infusion reaction that people associate with vancomycin belongs there too, because it is a monitoring story rather than a level story.

What surrounds the level

A level is never read on its own. It is read against the dose, the interval, the indication and how the patient's kidneys are handling the drug, since renal clearance is what determines where the trough lands.

It is also read against the patient in front of you. A number within target in someone who is deteriorating is not a reason to relax, and the level is not the endpoint of the assessment.

Ask what the drug is for. Ask when the level was drawn. Then read it.

What a trough actually is

A trough is the lowest concentration in the dosing interval, which is why it is drawn immediately before the next dose is given. That timing is not administrative detail.

Draw it early and the level reads higher than the true trough. Draw it after the dose has run and you are not measuring a trough at all.

So a nursing question about vancomycin monitoring is often really a question about timing. The correct action is frequently to make sure the level is drawn at the right moment, rather than to interpret whatever number came back.

Reading a vancomycin stem

A patient is on vancomycin for a serious infection and the reported trough sits inside 10 to 20 mcg/mL. They are no better than they were yesterday.

A number landing in range does not end the assessment. The target inside that band depends on the indication, and the level is a proxy rather than the outcome you actually care about.

So the reasonable response is to report the clinical picture alongside the level, not to file the level as reassurance and move on.

Why we do not print a table of levels

You will see charts listing peaks and troughs for a row of antibiotics. Ours has one line on it, and that is deliberate.

The class level source for aminoglycosides states there is no universal agreement on the monitoring method. Publishing a confident number where the literature does not support one would look more useful and be less true.

One sourced line beats five borrowed ones. That is the editorial policy in a sentence.

The wider lesson about drug levels

Drug monitoring is a good test of whether you are studying numbers or studying reasoning. Where a target genuinely exists, it usually depends on the indication, which is a decision rather than a recall exercise.

Anticoagulation makes that obvious. The INR target for atrial fibrillation is not the target for a mechanical mitral valve, which is the whole point of INR targets for atrial fibrillation and mechanical valves. Heparin goes further and abandons an absolute number altogether, monitored as a ratio against control, as explained in aPTT as a ratio instead of a number of seconds.

Three drugs, three different shapes of answer. That variety is the reason a single wall chart of levels never works, and it is why studying lab values by attaching an action to each one holds up better than memorising a table.